Loteflam Eye Drop contains Loteprednol etabonate 0.5% w/v, a corticosteroid indicated for the treatment of inflammatory conditions of the eye, including allergic conjunctivitis, postoperative inflammation, and anterior uveitis. Loteprednol etabonate is a synthetic glucocorticoid with potent anti-inflammatory properties that act by inhibiting the release of inflammatory mediators and suppressing the migration of polymorphonuclear leukocytes. This results in the reduction of ocular inflammation, edema, and redness. Loteflam Eye Drop is formulated for topical ophthalmic use, providing targeted relief with minimal systemic absorption. It is particularly useful in managing ocular inflammation while minimizing the risk of corticosteroid-related side effects such as increased intraocular pressure or cataract formation, due to its retrometabolic design. The recommended dosage and duration of treatment should be determined by a healthcare professional based on the severity of the condition. Patients should be monitored regularly for intraocular pressure changes during prolonged use. Loteflam Eye Drop is contraindicated in viral, fungal, or mycobacterial eye infections and should be used with caution in patients with a history of glaucoma or ocular hypertension. Proper administration technique and adherence to prescribed dosing are essential to maximize therapeutic efficacy and minimize adverse effects.